Quantification of cells expressing the thyrotropin receptor in extraocular muscles in thyroid associated orbitopathy

被引:56
作者
Boschi, A
Daumerie, C
Spiritus, M
Beguin, C
Senou, M
Yuksel, D
Duplicy, M
Costagliola, S
Ludgate, M
Many, MC
机构
[1] Catholic Univ Louvain, Dept Ophthalmol, B-1200 Brussels, Belgium
[2] Catholic Univ Louvain, Dept Endocrinol, B-1200 Brussels, Belgium
[3] Catholic Univ Louvain, Dept Biostat, B-1200 Brussels, Belgium
[4] Catholic Univ Louvain, Dept Expt Morphol & Gen Biol, B-1200 Brussels, Belgium
[5] Univ Libre Bruxelles, Inst Rech Interdisciplinaires, Brussels, Belgium
[6] UWCM, Dept Med, Cardiff, Wales
关键词
D O I
10.1136/bjo.2004.050807
中图分类号
R77 [眼科学];
学科分类号
100212 [眼科学];
摘要
Background/aim: Thyroid associated orbitopathy (TAO) and Graves' disease (GD) have an autoimmune pathogenesis, possibly related to the thyrotropin receptor (TSHR). The aim of this study was to determine whether TSHR immunoreactivity is correlated with disease severity or serum TSHR antibody (TRAB) levels. Methods: Orbital tissues from 30 patients with TAO were compared with those of 20 patients with strabismus and four with non-thyroid orbital inflammation. TSHR was detected by immunohistochemistry and TRAB were measured by radioreceptor assay. Results: No TSHR immunoreactivity was detected in the 24 control orbital tissues, whereas in all TAO biopsies elongated fibroblast-like cells, expressing TSHR, were present. These cells were located between the muscle cells, which were separated by oedema in the acute phase but fibrous tissue in the chronic phase of disease. Semi-thin sections showed numerous mast cells present in the chronic phase and in close contact with adipocytes. The number of TSHR immunostained cells was high in early disease, decreased with disease duration, and was positively correlated with TRAB levels at the onset of TAO. Conclusion: TSHR immunoreactivity was demonstrated specifically in TAO orbits which highlights the importance of TRAB early in the pathogenesis.
引用
收藏
页码:724 / 729
页数:6
相关论文
共 26 条
[1]
Thyrotropin receptor expression in Graves' orbital adipose/connective tissues: Potential autoantigen in Graves' ophthalmopathy [J].
Bahn, RS ;
Dutton, CM ;
Natt, N ;
Joba, W ;
Spitzweg, C ;
Heufelder, AE .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1998, 83 (03) :998-1002
[2]
Functional TSH receptor in human abdominal preadipocytes and orbital fibroblasts [J].
Bell, A ;
Gagnon, A ;
Grunder, L ;
Parikh, SJ ;
Smith, TJ ;
Sorisky, A .
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY, 2000, 279 (02) :C335-C340
[3]
Extrathyroidal manifestations of graves' disease: The thyrotropin receptor is expressed in extraocular, but not cardiac, muscle tissues [J].
Busuttil, BE ;
Frauman, AG .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2001, 86 (05) :2315-2319
[4]
Genetic immunization of outbred mice with thyrotropin receptor cDNA provides a model of Graves' disease [J].
Costagliola, S ;
Many, MC ;
Denef, JF ;
Pohlenz, J ;
Refetoff, S ;
Vassart, G .
JOURNAL OF CLINICAL INVESTIGATION, 2000, 105 (06) :803-811
[5]
Costagliola S, 1998, J IMMUNOL, V160, P1458
[6]
Crisp M, 2000, INVEST OPHTH VIS SCI, V41, P3249
[7]
Crisp MS, 1997, J CLIN ENDOCR METAB, V82, P2003
[8]
METAANALYSIS EVALUATION OF THE IMPACT OF THYROTROPIN RECEPTOR ANTIBODIES ON LONG-TERM REMISSION AFTER MEDICAL THERAPY OF GRAVES-DISEASE [J].
FELDTRASMUSSEN, U ;
SCHLEUSENER, H ;
CARAYON, P .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1994, 78 (01) :98-102
[9]
EXPRESSION OF THYROTROPIN-RECEPTOR MESSENGER-RNA IN HEALTHY AND GRAVES-DISEASE RETRO-ORBITAL TISSUE [J].
FELICIELLO, A ;
PORCELLINI, A ;
CIULLO, I ;
BONAVOLONTA, G ;
AVVEDIMENTO, EV ;
FENZI, G .
LANCET, 1993, 342 (8867) :337-338
[10]
CHANGES IN THYROID-STIMULATING IMMUNOGLOBULINS DURING ANTI-THYROID THERAPY [J].
FENZI, G ;
HASHIZUME, K ;
ROUDEBUSH, CP ;
DEGROOT, LJ .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1979, 48 (04) :572-576